In all three CCA subtypes, TE effectively inhibited tumour growth, although its impact was somewhat reduced in SNU‐1196 pCCA xenografts compared to CC‐LP‐1 iCCA or TFK‐1 dCCA xenografts. The gene discussed is RPLP1; the disease is neoplasm.